It looks like George Kirikos may have uncovered another large domain name sale. In a tweet this morning, George reported that Recursion Pharmaceuticals acquired the one word Recursion.com domain name for $904,000:
Recursion(.)com domain name was acquired for $904,000 by Recursion Pharmaceuticals @RecursionPharma in December 2020, according to pp. F-6, F-15, and 118 of their SEC filing at:https://t.co/BVhIspr8Zo
— George Kirikos (@GeorgeKirikos) March 27, 2021
The acquisition price information was found in the company’s SEC S-1 filing in advance of its IPO. On page F-15 of the S-1 under the “Intangible Asset Acquisitions” heading, the company reported the acquisition:
“Recursion Domain Name
In December 2020, the Company purchased the Recursion domain name for cash consideration of $904. The purchase price was capitalized as an intangible asset with an indefinite useful life.”
As with most corporate filings, the financial figures are in thousands, so “$904” means $904,000 USD. The company doesn’t specifically mention Recursion.com in that section, but Recursion.com is mentioned twice in the S-1 filing.
It is difficult to track the ownership history of this domain name in Whois records due to Whois privacy and GDPR redaction. It looks like it had been owned by a New York company at some point prior to the acquisition.
I added the sale of Recursion.com to the list of recent publicly reported one word .com domain name sales, and I am sure it will be added to DNJournal and NameBio where it will rank amongst the largest public domain name sales of 2020.